SEC Form 4 · accession 0001643071-16-000002
Axovant Sciences Ltd. · AXON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Atul Pande
Director
Period of report
Apr 29, 2016
Accepted (ET)
May 3, 2016 · 1:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001636050
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $13.00 | Apr 29, 2016 | A | 47,000 | A | Apr 29, 2017 | Apr 29, 2026 | Common Shares | 47,000 | 47,000 | D |
Explanation of responses
- F1100% of this option will vest one year after the date of grant. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
- F2Includes only options with the same termination date.